To the best of our knowledge, this is the first report of Mmp9 miR-376c mediated inhibition in human NSCLC, as well as miR-376c mediated Grb2 downregulation in MCPyV-positive tumour samples. This evidence concerns the gene MMP9 and non-small cell lung carcinoma.